JP2009526084A5 - - Google Patents

Download PDF

Info

Publication number
JP2009526084A5
JP2009526084A5 JP2008554516A JP2008554516A JP2009526084A5 JP 2009526084 A5 JP2009526084 A5 JP 2009526084A5 JP 2008554516 A JP2008554516 A JP 2008554516A JP 2008554516 A JP2008554516 A JP 2008554516A JP 2009526084 A5 JP2009526084 A5 JP 2009526084A5
Authority
JP
Japan
Prior art keywords
disease
pharmaceutical composition
composition according
inflammatory
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008554516A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009526084A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2007/061909 external-priority patent/WO2008039553A1/en
Publication of JP2009526084A publication Critical patent/JP2009526084A/ja
Publication of JP2009526084A5 publication Critical patent/JP2009526084A5/ja
Pending legal-status Critical Current

Links

JP2008554516A 2006-02-10 2007-02-09 可溶性ＩＬ−１７ＲＣｘ４および炎症における使用法 Pending JP2009526084A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77217706P 2006-02-10 2006-02-10
US78107806P 2006-03-10 2006-03-10
PCT/US2007/061909 WO2008039553A1 (en) 2006-02-10 2007-02-09 Soluble il-17rcx4 and methods of using in inflammation

Publications (2)

Publication Number Publication Date
JP2009526084A JP2009526084A (ja) 2009-07-16
JP2009526084A5 true JP2009526084A5 (OSRAM) 2010-03-18

Family

ID=38895865

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008554516A Pending JP2009526084A (ja) 2006-02-10 2007-02-09 可溶性ＩＬ−１７ＲＣｘ４および炎症における使用法

Country Status (10)

Country Link
US (2) US7622116B2 (OSRAM)
EP (1) EP1987058B1 (OSRAM)
JP (1) JP2009526084A (OSRAM)
AT (1) ATE467640T1 (OSRAM)
AU (1) AU2007300393B2 (OSRAM)
CA (1) CA2638819A1 (OSRAM)
DE (1) DE602007006429D1 (OSRAM)
ES (1) ES2347840T3 (OSRAM)
IL (1) IL192950A0 (OSRAM)
WO (1) WO2008039553A1 (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101001871A (zh) * 2004-06-10 2007-07-18 津莫吉尼蒂克斯公司 可溶性ZcytoR14、抗ZcytoR14抗体和结合伴侣以及在炎症中的使用方法
CA2679588A1 (en) 2007-03-26 2008-10-02 Zymogenetics, Inc. Soluble il-17ra/rc fusion proteins and related methods
AU2008266745B2 (en) * 2007-06-20 2014-04-17 Merck Sharp & Dohme Corp. Joint destruction biomarkers for anti-IL-17A therapy of inflammatory joint disease
GB2464183A (en) * 2008-09-19 2010-04-14 Singulex Inc Sandwich assay
WO2010096394A2 (en) 2009-02-17 2010-08-26 Redwood Biosciences, Inc. Aldehyde-tagged protein-based drug carriers and methods of use
EP2810652A3 (en) * 2009-03-05 2015-03-11 AbbVie Inc. IL-17 binding proteins
AU2010259022B2 (en) 2009-06-08 2016-05-12 Singulex, Inc. Highly sensitive biomarker panels
JP2011032170A (ja) * 2009-07-29 2011-02-17 Morinaga Milk Ind Co Ltd ヒト細胞ｉｌ−１７産生抑制剤
US20130011413A1 (en) * 2010-02-03 2013-01-10 The University Of Tokyo Method and Pharmaceutical Composition for Treatment of Intestinal Disease
WO2011140484A1 (en) 2010-05-06 2011-11-10 Singulex, Inc Methods for diagnosing, staging, predicting risk for developing and identifying treatment responders for rheumatoid arthritis
RU2535033C2 (ru) * 2010-08-06 2014-12-10 Олег Ильич Эпштейн Лекарственное средство и способ профилактики инфицирования вич, профилактики и лечения заболеваний, вызываемых вич или ассоциированных с вич, в том числе спида
EP2663647A4 (en) 2011-01-14 2015-08-19 Redwood Bioscience Inc POLYPEPTIDE IMMUNOGLOBULINS WITH ALDEHYDIC MARKING AND THEIR USE METHOD
US9284283B2 (en) 2012-02-02 2016-03-15 Ensemble Therapeutics Corporation Macrocyclic compounds for modulating IL-17
US11492396B2 (en) 2015-10-27 2022-11-08 UCB Biopharma SRL Methods of treatment using anti-IL-17A/F antibodies
US11208632B2 (en) 2016-04-26 2021-12-28 R.P. Scherer Technologies, Llc Antibody conjugates and methods of making and using the same
WO2020147829A1 (zh) * 2019-01-17 2020-07-23 北京百奥赛图基因生物技术有限公司 人源化转基因动物
BR112022002962A2 (pt) 2019-08-16 2022-07-05 Applied Molecular Transport Inc Composições, formulações e produção e purificação de interleucina
CN112250764B (zh) * 2020-10-22 2022-07-29 深圳市康瑞克生物科技有限责任公司 一种抗白细胞介素17a的单克隆抗体、其编码基因及应用

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5684032A (en) 1994-12-13 1997-11-04 Smithkline Beecham Corporation Compounds
MX9707021A (es) 1995-03-23 1997-11-29 Immunex Corp Receptor de il-7.
US5945511A (en) 1997-02-20 1999-08-31 Zymogenetics, Inc. Class II cytokine receptor
WO1999058660A1 (en) 1998-05-12 1999-11-18 Human Genome Sciences, Inc. 97 human secreted proteins
US6569645B2 (en) 1999-05-14 2003-05-27 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
US20020177188A1 (en) 1998-05-15 2002-11-28 Genentech, Inc. IL-17 homologous polypeptides and therapeutic uses thereof
US6579520B2 (en) 1998-05-15 2003-06-17 Genentech, Inc. IL-17 related mammalian cytokine polypeptides (IL-17E)
WO1998049307A1 (en) 1997-05-01 1998-11-05 Zymogenetics, Inc. Mammalian cytokine-like receptor
US5965704A (en) 1997-08-05 1999-10-12 Zymogenetics, Inc. Class two cytokine receptor-11
DE69841140D1 (de) 1997-09-17 2009-10-22 Human Genome Sciences Inc Interleukin-17 rezeptor-ähnliches protein
DK1190056T3 (da) 1999-07-07 2007-07-30 Zymogenetics Inc Human cytokin receptor
US20030199041A1 (en) 1999-07-07 2003-10-23 Presnell Scott R. Interleukin-17 receptor homologue
ATE519847T1 (de) 1999-12-23 2011-08-15 Genentech Inc Il-17-homologe polypeptide und ihre therapeutische verwendung
US20030092881A1 (en) 2000-05-24 2003-05-15 Gorman Daniel M. Mammalian receptor proteins; related reagents and methods
WO2001090357A1 (en) 2000-05-24 2001-11-29 Genesis Research & Development Corporation Limited Compositions isolated from skin cells and methods for their use
WO2002058717A2 (en) * 2000-10-18 2002-08-01 Immunex Corporation Methods for treating rheumatoid arthritis using il-17 antagonists
US20040171109A1 (en) 2000-11-10 2004-09-02 Dominik Haudenschild IL-17 receptor-like protein, uses thereof, and modulation of catabolic activity of il-17 cytokines on bone and cartilage
US20040097447A1 (en) 2002-11-16 2004-05-20 Isis Pharmaceuticals Inc. Modulation of interleukin 22 receptor expression
CN101001871A (zh) 2004-06-10 2007-07-18 津莫吉尼蒂克斯公司 可溶性ZcytoR14、抗ZcytoR14抗体和结合伴侣以及在炎症中的使用方法
CA2596509A1 (en) * 2005-02-14 2006-08-24 Wyeth Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor
WO2007038703A2 (en) * 2005-09-28 2007-04-05 Zymogenetics, Inc Il-17a and il-17f antagonists and methods of using the same
US20070249533A1 (en) * 2005-09-28 2007-10-25 Levin Steven D Il-17a and il-17f antagonists and methods of using the same

Similar Documents

Publication Publication Date Title
JP2009526084A5 (OSRAM)
JP2008509227A5 (OSRAM)
JP2009510093A5 (OSRAM)
JP2020193195A5 (OSRAM)
JP2010511056A5 (OSRAM)
JP2018154628A5 (OSRAM)
JP2011526792A5 (OSRAM)
JP6181145B2 (ja) 改善された特異性を有する新規免疫グロブリン結合タンパク質
US9920098B2 (en) Protein ligand for affinity isolation matrix
FI3592384T3 (fi) Vasta-aineita, jotka spesifisesti sitoutuvat ihmisen IL-1R7:ään
RU2009124453A (ru) Гетеродимерные полипептиды il-17 a/f и возможности их лечебного применения
CN114957472B (zh) 抗IL-4Rα的单域抗体以及应用和药物
JP2017510575A5 (OSRAM)
CN104098694B (zh) 抗人β2微球蛋白的单域抗体及其制备方法和用途
JP2010500005A5 (OSRAM)
RU2017118325A (ru) Слитые серпиновые полипептиды и способы их применения
JP2010220614A5 (OSRAM)
RU2017145308A (ru) Слитые серпиновые полипептиды и способы их применения
JP2014530611A5 (OSRAM)
JP2015511637A5 (OSRAM)
JP2016510736A5 (OSRAM)
JP2015524790A5 (OSRAM)
JP2011524858A5 (OSRAM)
JP2013537414A5 (OSRAM)
JP2011520959A5 (OSRAM)